Free AccessLetters to the EditorEvaluating sleep quality with coronavirus disease 2019 (COVID-19) testing Katie Viehmann-Wical, DrPHc, MCHES, RRT-NPS Katie Viehmann-Wical, DrPHc, MCHES, RRT-NPS Search for more papers by this author Published Online:February 1, 2021https://doi.org/10.5664/jcsm.8966SectionsAbstractPDF ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations AboutABSTRACTCitation:Viehmann-Wical K. Evaluating sleep quality with coronavirus disease 2019 (COVID-19) testing. J Clin Sleep Med. 2021;17(2):355.INTRODUCTIONWhat a great time to be in sleep medicine! This is the perfect time for sleep specialists to speak up about the immune-boosting, virus-fighting health benefits of sleep.Rapid eye movement (REM) sleep is the key sleep cycle for fighting viruses.1–3 The 2–5% of patients positive for coronavirus disease 2019 (COVID-19) admitted into the hospital and intensive care units are most likely patients with REM sleep problems. Asking patients getting tested for COVID-19 if they have untreated snoring (even better using a Pittsburgh Sleep Quality Index form) would quickly identify the high-risk population for sleep problems and worse COVID-19 prognosis.Promoting sleep health and educating individuals how to protect REM sleep would decrease deaths, restore economic stability, and decrease severity for the 2–5% of individuals admitted for COVID-19 treatment. Unfortunately, sleep health knowledge and understanding are low among health care providers and even lower within the general public.4The 3 main underknown health challenges that fragment, block, or decrease REM sleep are as follows: undiagnosed and untreated nightly snoring/sleep apnea,5 drinking alcohol within 6 hours of bedtime,6 or having caffeinated products in the last 6 to 8 hours before bed.7 Sleep specialists are key to diagnosing and treating chronic snoring and sleep apnea, plus educating patients about major risk factors that decrease high-quality REM sleep.The key area where sleep specialists can decrease virus severity is with patients with undiagnosed/untreated sleep apnea. Sleep apnea fragments and blocks REM sleep,5 decreasing immunity.1,3 Apnea is also associated with gut dysbiosis, leading to weight gain and hormone imbalance.8 A body mass index, especially over 40 kg/m2 in males, is associated with higher risk of COVID-19 symptoms and death.9 Diagnosing and treating the nearly one-quarter of females and one-half of males10 with undiagnosed moderate–severe chronic snoring/apnea would protect health and ability to fight off viruses.1,3DISCLOSURE STATEMENTThe author has seen and approved this manuscript. The author reports no conflicts of interest.REFERENCES1. Irwin MR. Sleep and inflammation: partners in sickness and in health. Nat Rev Immunol. 2019;19(11):702–715. https://doi.org/10.1038/s41577-019-0190-z CrossrefGoogle Scholar2. Redwine L, Dang J, Hall M, Irwin M. Disordered sleep, nocturnal cytokines, and immunity in alcoholics. Psychosom Med. 2003;65(1):75–85. https://doi.org/10.1097/01.PSY.0000038943.33335.D2 CrossrefGoogle Scholar3. Moldofsky H. Sleep and the immune system. Int J Immunopharmacol. 1995;17(8):649–654. https://doi.org/10.1016/0192-0561(95)00051-3 CrossrefGoogle Scholar4. Jaiswal SJ, Owens RL, Malhotra A. Raising awareness about sleep disorders. Lung India. 2017;34(3):262–268. Google Scholar5. Kimoff RJ. Sleep fragmentation in obstructive sleep apnea. Sleep. 1996;19(9, Suppl):S61–S66. https://doi.org/10.1093/sleep/19.suppl_9.S61 CrossrefGoogle Scholar6. Stein MD, Friedmann PD. Disturbed sleep and its relationship to alcohol use. Subst Abus. 2005;26(1):1–13. https://doi.org/10.1300/J465v26n01_01 CrossrefGoogle Scholar7. Drake C, Roehrs T, Shambroom J, Roth T. Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed. J Clin Sleep Med. 2013;9(11):1195–1200. https://doi.org/10.5664/jcsm.3170 LinkGoogle Scholar8. Mashaqi S, Gozal D. Obstructive sleep apnea and systemic hypertension: gut dysbiosis as the mediator? J Clin Sleep Med. 2019;15(10):1517–1527. https://doi.org/10.5664/jcsm.7990 LinkGoogle Scholar9. Tartof SY, Qian L, Hong V, et al.. Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization. Ann Intern Med. 2020;173(10):773–781. CrossrefGoogle Scholar10. Heinzer R, Vat S, Marques-Vidal P, et al.. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3(4):310–318. https://doi.org/10.1016/S2213-2600(15)00043-0 CrossrefGoogle Scholar Previous article Next article FiguresReferencesRelatedDetails Volume 17 • Issue 2 • February 1, 2021ISSN (print): 1550-9389ISSN (online): 1550-9397Frequency: Monthly Metrics History Submitted for publicationOctober 19, 2020Submitted in final revised formOctober 27, 2020Accepted for publicationOctober 27, 2020Published onlineFebruary 1, 2021 Information© 2021 American Academy of Sleep MedicinePDF download
Read full abstract